Fingolimod lauryl sulfate
HealthData.Gov
Updated Oct 29, 2026
About this dataset
TASCENSO ODT is an orally disintegrating tablet prescription drug containing fingolimod lauryl sulfate, available in 0.25 mg and 0.5 mg strengths. It acts as a sphingosine 1-phosphate receptor modulator, manufactured by Cycle Pharmaceuticals Ltd for oral use. This information was generated using AI and is provided for informational and research purposes only.
Data and resources (1)
- HTML
Fingolimod lauryl sulfate
Access the FDA dataset for Fingolimod lauryl sulfate — ANDA 214962 submitted by Mylan Institutional LLC
Modified Apr 29, 2026